IGFBP2 and metabolic dysfunction-associated steatotic liver disease: Interestingly, in models of dietary NAFLD induction, hypermethylation of IGFBP2 precedes the onset of hepatic steatosis development when mice were still metabolically stable, suggesting its potential as a risk indicator of liver disease development [178].